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Backgrounds/Aims: Interest in treatments for elderly patients has increased with life expectancy, and various studies 
have reported on the safety and feasibility of radical surgery in elderly patients with cancer. Here, we investigated 
oncologic outcomes of periampullary cancer in octogenarians. Methods: We retrospectively reviewed medical records 
of 68 patients over 80 years of age who were diagnosed with periampullary cancer and were eligible for surgery; 
we analyzed overall survival (OS) and immediate postoperative complications and mortality. Results: There were no 
significant differences in mean age, disease type, oncologic features, comorbidities, or nutritional status between the 
patients who had surgery and those who did not. Five patients (20.0%) had major postoperative complications, but 
there was no immediate postoperative mortality. Patients who had surgery (n=25) had better OS (29.3 months; 95% 
confidence interval [CI]: 5.6-53.0) than did those who did not (n=43, OS: 7.6 months; 95% CI: 3.2-12.0 months; p
＜0.001). Similarly, patients with distal common bile duct cancer who underwent surgery had better OS than those 
who did not (surgery group: n=13, OS: 29.3 months, 95% CI: 8.9-49.7; non-surgery group: n=15, OS: 5.7 months, 
95% CI: 4.2-7.2 months; p=0.002). Conclusions: Radical surgery for octogenarian patients with periampullary cancer 
is safe, feasible, and expected to result in better survival outcomes, especially for patients with common bile duct 
cancer. (Ann Hepatobiliary Pancreat Surg 2018;22:128-135)
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INTRODUCTION
Increased life expectancy is a global trend; over the 
past two decades, the mean life expectancy has increased 
from 64 to 71 years of age, and moreover, the mean life 
expectancy in high-income countries has increased to 
nearly 80 years.1 The incidence of cancer increases with 
age, generating an increased interest in treatments for eld-
erly individuals,2 and therefore, researchers have con-
ducted many studies on surgeries for elderly patients with 
cancer; clinicians have found that most such surgeries are 
both safe and feasible, with immediate surgical complica-
tions, mortality rates, and long-term outcomes comparable 
with those in younger patients.3-6
Researchers have also reported in multiple studies the 
efficacy of radical surgery for elderly patients with peri-
ampullary adenocarcinoma, and some have reported that 
selected elderly patients could have similar perioperative 
outcomes and overall survival (OS) to those in younger 
adults, although others have shown increased morbidity 
and mortality in elderly versus younger patients.7-10 In 
short, the efficacy of surgery for elderly patients with per-
iampullary adenocarcinoma remains a controversial issue 
in the hepato-pancreato-biliary surgery field.
There are a number of causes for the controversy. 
Periampullary cancer tends to occur later in life than other 
malignancies: The median age at diagnosis is about 70 
years.2,11,12 Moreover, pancreatoduodenectomy, the radical 
surgery that is generally performed for such cancers, caus-
es more morbidity and mortality and results in poorer 
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Fig. 1. Age distribution of patients with periampullary cancer.
Table 1. Basal characteristics of the patients
N=68
Age in years (range)   82 (80-83)
Gender (M:F) 37:31 (1.19:1)
BMI   22.7±0.8
Location of Cancer
  CBD   28 (41.2%)
  Pancreas   16 (23.5%)
  AoV   16 (23.5%)
  Duodenum    8 (11.8%)
Differentiation
  Well   13 (19.1%)
  Moderately   25 (36.8%)
  Poorly   10 (14.7%)
  Unknown   20 (29.4%)
CEA (ng/ml)  2.63 (1.69-4.07)
CA 19-9 (U/ml)  127 (24-605)
Chemotherapy   12 (17.6%)
Radiotherapy    8 (11.8%)
Comorbidity   52 (76.5%)
  HTN   45 (66.2%)
  DM   14 (20.6%)
CCS (≥3)   21 (30.9%)
ASA score (≥3)   12 (17.6%)
POSSUM score   21 (19-23)
Albumin (g/dl)    3.6±0.1
Lymphocyte (103/l)   1.43±0.2
GNRI   95.7±2.5
BMI, body mass index; CBD, common bile duct; AoV, am-
pulla of Vater; CEA, carcinoembryonic antigen; CA 19-9, 
cancer antigen 19-9; HTN, hypertension; DM, diabetes melli-
tus; CCS, Charlson comorbidity score; ASA, American 
Society of Anesthesiologists; POSSUM, physiological and 
operative severity score for the enumeration of mortality and 
morbidity; GNRI, geriatric nutrition risk index
prognoses than do treatments for other gastrointestinal 
cancers.2,13 Therefore, advanced age has been associated 
with decreased utilization of surgery to treat periampullary 
cancer, and the mean age of patients who undergo surgery 
has remained unchanged over the past decade.14
In recent decades, surgical techniques and postoperative 
care have significantly improved, and morbidity and mor-
tality after radical surgery have decreased dramatically 
while mean life expectancy has increased.1,13,15 Moreover, 
radical surgery remains the only potentially curative treat-
ment for periampullary cancer.16 Therefore, it is necessary 
to evaluate radical surgery for periampullary cancer in 
elderly patients in light of the recent improvements in 
techniques. We investigated the oncologic outcomes of 
periampullary cancer in octogenarians, comparing patients 
who did not receive surgery with those who underwent 
radical surgery.
MATERIALS AND METHODS
We retrospectively reviewed the medical records of 133 
patients over 80 years of age who were diagnosed with 
periampullary cancer from January 2005 to December 
2014. We excluded 65 patients who were not able to have 
radical surgery at the time of diagnosis (e.g., those with 
distant metastasis) or who were not confirmed by pathol-
ogy to have periampullary cancer, and we divided the re-
maining patients into two groups based on whether or not 
they underwent radical surgery. The surgical criteria for 
the elderly patients were the same as those for non-elderly 
patients, and those who were deemed to be operable 
through preoperative study underwent the surgery. We an-
alyzed immediate postoperative complications and mortal-
ity in the patients who had surgery and compared the OS 
period between the patients who underwent surgery and 
those who did not.
We used SPSS version 20.0 (IBM Corp., Armonk, NY, 
USA) for all statistical analyses, and we compared nomi-
nal data with x2 tests, continuous parametric data with t- 
test, and nonparametric data with Mann-Whitney U tests. 
We assessed survival parameters by the Kaplan-Meier 
method and compared them using the log-rank test. The 
criterion for statistical significance was p＜0.05.
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Table 2. Basal characteristics of the patients according to treatment
Non-surgery (n=43) Surgery (n=25) p value
Age in years (range)   83 (80-84)   82 (80-83) 0.101
Gender (M:F) 23:20 (1.15:1) 14:11 (1.27:1) 0.841
BMI (range)  22.5 (16.5-32.1)  23.1 (16.8-29.6) 0.686
Location of Cancer 0.304
  CBD   15 (34.9%)   13 (52.0%)
  Pancreas   12 (27.9%)    4 (16.0%)
  AoV   12 (27.9%)    4 (16.0%)
  Duodenum    4 (9.3%)    4 (16.0%)
Differentiation 0.752
  Well    9 (20.9%)    4 (16.0%)
  Moderately   14 (32.6%)   11 (44.0%)
  Poorly    6 (13.9%)    4 (16.0%)
  Unknown   14 (32.6%)    6 (24.0%)
CEA (＞5 ng/ml)    8 (18.6%)    2 (8.0%) 0.228
CA 19-9 (＞37 U/ml)   34 (79.1%)   16 (64.0%) 0.170
Chemotherapy    5 (11.6%)    7 (28.0%) 0.088
Radiotherapy    6 (14.0%)    2 (8.0%) 0.463
Comorbidity   34 (79.0%)   18 (72.0%) 0.508
  HTN   29 (67.4%)   16 (64.0%) 0.772
  DM    9 (20.9%)    5 (20.0%) 0.927
CCS (≥3)   15 (34.9%)    6 (24.0%) 0.349
ASA score (≥3)   10 (23.3%)    2 (8.0%) 0.112
POSSUM score (≥24)   16 (37.2%)    6 (24.0%) 0.262
Albumin (＜3.0 g/dl)    4 (9.3%)    1 (4.0%) 0.419
Lymphocyte (＜2000/l)   35 (81.4%)   21 (84.0%) 0.786
GNRI (≥3)   18 (43.9%)    7 (28.0%) 0.196
BMI, body mass index; CBD, common bile duct; AoV, ampulla of Vater; CEA, carcinoembryonic antigen; CA 19-9, cancer 
antigen 19-9; HTN, hypertension; DM, diabetes mellitus; CCS, Charlson comorbidity score; ASA, American Society of 
Anesthesiologists; POSSUM, physiological and operative severity score for the enumeration of mortality and morbidity; GNRI, 
geriatric nutrition risk index
Fig. 2. Reasons for refusal of operation in Non-surgery group.
RESULTS
Patient distribution
From January 2005 to December 2014, 2,077 patients 
were diagnosed with periampullary cancer in our hospital, 
and among them, 133 (6.4%) were over 80 years of age. 
More than half of the patients were age 60 to 70 (1,278 
patients, 61.6%), and the oldest patient with pancreatic 
cancer was 96, although that patient was inoperable at the 
time of diagnosis (Fig. 1).
Baseline patient characteristics
The clinicopathologic characteristics of the 68 patients 
over age 80 who were diagnosed with periampullary can-
cer are shown in Table 1. The median patient age was 
82 years, and the oldest was 90; this patient was in the 
surgery group. Fifty-two patients (76.5%) had at least one 
comorbidity. The mean geriatric nutritional risk index 
(GNRI) was 95.7 (95% confidence interval [CI]: 93.2-98.2).
Characteristics of the non-surgery group
Most patients (n=31, 72.1%) refused the surgery due to 
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Fig. 3. (A) TNM stage and (B) complications in elderly patients after surgery in elderly patients with periampullary cancer
at the duodenum, ampulla of Vater (AoV), pancreas and common bile duct.
their old age, and the other patients’ data did not exist 
in the medical records (n=12, 27.9%). Among the patients 
who refused the surgery, 14 decided independently, and 
family members made the decision for the other 17 (Fig. 
2).
Clinicopathologic characteristics according to 
radical surgery
We divided the 68 patients into two groups based on 
whether or not they underwent radical surgery. Forty-three 
patients did not undergo surgery, and the other 25 did, 
and there was no significant difference in median age be-
tween the two groups (non-surgery: 83 years, surgery: 82; 
years p=0.101). There were also no significant differences 
in tumor characteristics (tumor location and differ-
entiation), comorbidity status (Charlson comorbidity score 
[CCS] and American Society of Anesthesiologist [ASA] 
classification), or nutritional status including GNRI (Table 
2).
Characteristics of the surgery group
Most of the patients who underwent radical surgery 
were within TNM stage II; only two were beyond stage 
II, and both of them were confirmed to have duodenal 
cancer (Fig. 3A). Twenty-two patients (88.0%) had imme-
diate postoperative complications; however, most of the 
complications were minor, and only five (20.0%) had ma-
jor complications that exceeded Clavien-Dindo grade III17 
(Fig. 3B). Between the elderly and non-elderly (n=678) 
groups, there were no significant differences in complica-
tion rates (elderly: 11.5%, non-elderly: 20.0%; p=0.202).
Oncologic outcomes of elderly patients
The mean OS was 37.7 months (range: 26.1-49.3 
months), and there was a significant difference in OS be-
tween the two groups (non-surgery vs. surgery: 7.6 
months vs. 29.3 months; p＜0.001). Fifty-six patients 
(82.4%) expired, and all of the causes of death were can-
cer related (Fig. 4A).
Subgroup analysis showed that patients with common 
bile duct (CBD) cancer who underwent surgery (n=13) 
had better OS than did those with CBD cancer who did 
not (n=15): 5.7 months vs. 29.3 months (p=0.002). 
However, there were no significant differences between 
the two groups in clinicopathologic parameters except for 
CCS (non-surgery vs. surgery: 0.0% vs. 30.8%, p=0.035; 
Table 3). Comparisons among other subgroups either 
showed no significant differences between patients in the 
surgery and non-surgery groups or could not provide stat-
istical results because of the small sample sizes of the 
subgroups (Fig. 4B-E).
DISCUSSION
As the human body ages, there is a progressive decline 
in physiologic functioning that affects all organ systems 
and places elderly individuals at increased risk of disease. 
Although the gastrointestinal system is less affected than 
other systems, aging can lead to a decline in metabo-
lism,18 and moreover, aging is a risk factor for most 
cancers. There is abundant literature that explains the rela-
tionship between aging and cancer. Carcinogenesis often 
occurs over a long period of time and is promoted by the 
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Fig. 4. Overall survival rates of elderly patients with peri-
ampullary cancer; (A) Total, (B) common bile duct (CBD), 
(C) Pancreas, (D) Ampulla of Vater (AoV) and (E) 
Duodenum.
increased susceptibility of older tissues to environmental 
carcinogens and by changes in the body environment that 
occur with aging, such as chronic inflammation and in-
creased resistance to insulin.19,20 Therefore, elderly pa-
tients should not be considered to be the same as younger 
patients.
There are few evidence-based guidelines for elderly pa-
tients with cancer, and oncologists are often faced with 
special challenges when managing these patients;21 most 
oncologists agree, however, that estimating life expect-
ancy is of primary importance. In addition, clinicians 
should determine whether the assumed treatment benefits 
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Table 3. Basal characteristics of elderly patients with distal CBD cancer
Non-surgery (n=15) Surgery (n=13) p value
Age in years (range)  81 (80-88)  81 (80-90) 0.446
Gender (M:F)  6:9 (0.67:1)  7:6 (1.17:1) 0.464
BMI (range) 22.7 (20.5-24.9) 23.3 (21.4-25.2) 0.686
Differentiation 0.469
  Well   6 (40.0%)   3 (23.1%)
  Moderately   7 (46.6%)   5 (38.5%)
  Poorly   1 (6.7%)   2 (15.3%)
  Unknown   1 (6.7%)   3 (23.1%)
CEA (＞5 ng/ml)   1 (6.7%)   2 (15.3%) 0.457
CA 19-9 (＞37 U/ml)  13 (86.7%)   6 (31.6%) 0.051
Chemotherapy   1 (6.7%)   1 (7.7%) 0.916
Radiotherapy   2 (13.3%)   2 (15.4%) 0.463
Comorbidity  11 (73.3%)  10 (76.9%) 0.827
  HTN  11 (73.3%)   8 (61.5%) 0.505
  DM   1 (6.7%)   3 (23.1%) 0.216
CCS (≥3)   0 (0.0%)   4 (30.8%) 0.035
ASA score (≥3)   2 (13.3%)   2 (15.4%) 0.877
POSSUM score (≥24)   4 (26.7%)   4 (30.8%) 0.811
Albumin (＜3.0 g/dl)   2 (13.3%)   0 (0.0%) 0.172
Lymphocyte (＜2000/l)  13 (86.7%)  11 (84.6%) 0.877
GNRI (≥3)   9 (64.3%)   3 (23.1%) 0.054
BMI, body mass index; CBD, common bile duct; AoV, ampulla of Vater; CEA, carcinoembryonic antigen; CA 19-9, cancer 
antigen 19-9; HTN, hypertension; DM, diabetes mellitus; CCS, Charlson comorbidity score; ASA, American Society of 
Anesthesiologists; POSSUM, physiological and operative severity score for the enumeration of mortality and morbidity; GNRI, 
geriatric nutrition risk index
will likely occur within the patient’s remaining life span. 
Because life expectancy is heterogeneous among elderly 
patients, it is not a simple issue to determine the likely 
efficacy of a given treatment; comorbidities, disability, 
and geriatric syndromes have a substantial impact on life 
expectancy.22
Because of the complexities of cancer management in 
elderly patients, comprehensive geriatric assessment 
(CGA) is in the interest of oncologists. CGA is a global, 
multidisciplinary approach to elderly patients that covers 
functional status, cognitive capacities, emotional status, 
comorbidities, nutritional status, polypharmacy, and social 
and environmental circumstances.23 Recently, several 
studies showed that CGA could help to adapt cancer man-
agement to each patient’s fitness or frailty.24,25 Although 
CGA can predict morbidity and mortality in elderly pa-
tients with cancer, its implications are more complex for 
surgical oncologists;23 surgery is one of the most invasive 
treatments and can cause more complications than other 
treatment modalities.26 Above all, radical surgery for peri-
ampullary cancer is generally associated with high mor-
bidity and mortality rates and requires many days of hos-
pitalization, leading to fears among surgical oncologists 
about treatment-related adverse effects.13
To avoid unwanted postoperative morbidity and mortal-
ity, researchers have conducted many studies on pre-
dictive preoperative indexes for elderly patients,26-29 and 
comorbidities are one of the risk factors. Eighty-three per-
cent of elderly patients have at least one comorbidity, al-
though two thirds have acceptable preoperative functional 
and mental status.26,28 In addition, the ASA grade and the 
GNRI can predict postoperative complications;27,29,30 in 
our study, there was no significant difference in ASA 
grade or GNRI between the patients who underwent radi-
cal surgery and those who did not. The CCS and the 
Physiological and Operative Severity Score for the enUm-
eration of Mortality and morbidity (POSSUM) are addi-
tional predictive factors, although their predictive value 
has not been validated in elderly patients;31,32 in our study, 
there was no significant difference in these scores be-
tween the elderly and non-elderly patients.
Many studies that evaluated safety, feasibility, and out-
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comes in elderly patients with periampullary cancer have 
been conducted, but most of these studies defined elderly 
patients as septuagenarians;7,33-35 there are only a few re-
ports on octogenarians, and these showed major post-
operative complication rates from 32.2 to 50.0%.10,36,37 In 
our study, the major complication rate was 20.0%, and the 
lower rate in our study was likely because we included 
recent operations; our rate was similar to the rate in an-
other recent report of complication rates.38 In addition, 
with the exception of the patients with duodenal cancer, 
the TNM stages of periampullary adenocarcinoma in our 
study were below stage III. Our results suggest that the 
patients in our study who underwent surgery were surgi-
cally and oncologically appropriate for the treatment they 
received.
Although we could not directly know the TNM stages 
of the patients in the non-surgery group, there were no 
significant differences in tumor markers or tumor differ-
entiation between the surgery and non-surgery groups; we 
therefore inferred indirectly that there were likely not sig-
nificant differences in TNM stages between the two 
groups. In addition, we performed a subgroup analysis to 
compensate for the heterogeneity of the study group, and 
that analysis showed that patients with distal CBD cancer 
who underwent surgery had better OS than did those who 
did not, although there were no differences in baseline 
characteristics between the two groups except for CCS, 
which was higher in the surgery subgroup than in the 
non-surgery group.
The main focus of the previous articles on octoge-
narians was not oncologic outcomes but rather surgical 
safety and feasibility,8,37,39 whereas we evaluated not only 
surgical safety and feasibility but also surgical oncologic 
outcomes; moreover, the control group in our study con-
sisted of elderly patients who did not undergo surgery. 
Most of the previous studies compared elderly patients 
with younger patients to evaluate the oncologic out-
comes,7,8,34,35,37,39 whereas comparison between two elderly 
groups in our study excluded potential confounding fac-
tors related to aging and showed the effectiveness of radi-
cal surgery for elderly patients with periampullary cancer. 
What we found was that the octogenarian patients with 
periampullary cancer who were operable and did not have 
physiologic conditions that precluded radical surgery had 
good oncologic outcomes without serious complications.
Our study has major limitations due to its retrospective 
design and its heterogeneous study group, which was af-
fected by various diseases; although the subgroup analysis 
accounted for the heterogeneity of the study group, we 
were only able to statistically analyze the subgroup with 
distal CBD cancer because of the small sample size. 
Moreover, in elderly patients, quality of life is as im-
portant as life expectancy, and because of the retro-
spective study design, we could not include parameters 
that estimated the elderly patients’ quality of life.
Nevertheless, our study provides significant results con-
cerning radical surgery for elderly patients with peri-
ampullary cancer. Specifically, radical surgery for certain 
octogenarian patients with periampullary cancer is safe 
and feasible and can be expected to result in better surviv-
al outcomes, especially for patients with CBD cancer. 
Further study is warranted to develop a more sophisticated 
system for selecting elderly patients to obtain better 
outcomes.
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